Patent ID: 11957748
Assignee: 21C BIO
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A method for preventing acquired immune deficiency syndrome (AIDS) in a subject in need thereof, comprising administering to the subject:
1) A CD8 vaccine specific for at least one human immunodeficiency virus (HIV) antigen,
2) optionally interferon-alpha blocking agent, and
3) A type III interferon and/or an agent stimulating the production of type III interferon, wherein the type III interferon comprises at least one IFN-λ selected from the group of IFN-λ1, IFN-λ2 IFN-λ3 and IFN-λ4, and wherein the agent stimulating the production of type III interferon comprises at least one TLR ligand, RIG-I ligand, and/or MDA5 ligand.